Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.82 USD | -3.48% | -4.43% | +35.98% |
May. 09 | Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 62.62M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.54
x | P/E ratio 2025 * |
-3.06
x | Employees | 21 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.25% |
Latest transcript on Lantern Pharma Inc.
1 day | -3.48% | ||
1 week | -4.43% | ||
Current month | +14.12% | ||
1 month | +8.99% | ||
3 months | +45.86% | ||
6 months | +44.42% | ||
Current year | +35.98% |
Managers | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
David Margrave
DFI | Director of Finance/CFO | 64 | 18-05-31 |
Reggie Ewesuedo
CTO | Chief Tech/Sci/R&D Officer | - | 23-03-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Panna Sharma
CEO | Chief Executive Officer | 53 | 18-06-30 |
Director/Board Member | 73 | 22-06-07 | |
Donald Keyser
CHM | Chairman | 71 | 17-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 5.82 | -3.48% | 88,302 |
24-05-17 | 6.03 | -1.79% | 44,056 |
24-05-16 | 6.14 | -3.00% | 44,239 |
24-05-15 | 6.33 | +2.26% | 86,064 |
24-05-14 | 6.19 | +1.64% | 64,232 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.98% | 64.88M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- LTRN Stock